Avui, dilluns 8 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
Hoy, lunes 8 de junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Today, Monday, Jun 8th, the Digital Repository will be unavailable due to a system update.

Files

Montaner-Tarbes_S_Sci_Rep_2018.pdf (1.9 MB)

Document type

Article

Version

Published version

Publication date

2018-11-30

Publication license

cc by (c) Montaner Tarbes et al., 2018
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/134880

Targeted-pig trial on safety and immunogenicity of serum-derived extracellular vesicles enriched fractions obtained from Porcine Respiratory and Reproductive virus infections

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1038/s41598-018-36141-5

Abstract

The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is the etiological agent of one of the most important swine diseases with a significant economic burden worldwide. Unfortunately, available vaccines are partially effective highlighting the need of novel approaches. Previously, antigenic viral proteins were described in serum-derived extracellular vesicles (EVs) from pigs previously infected with PRRSV. Here, a targeted-pig trial was designed to determine the safety and immunogenicity of such extracellular vesicles enriched fractions. Our results showed that immunizations with EV-enriched fractions from convalescence animals in combination with montanide is safe and free of virus as immunizations with up-to two milligrams of EV-enriched fractions did not induce clinical symptoms, adverse effects and detectable viral replication. In addition, this vaccine formulation was able to elicit specific humoral IgG immune response in vaccinated animals, albeit variably. Noticeably, sera from vaccinated animals was diagnosed negative when tested for PRRSV using a commercial ELISA test; thus, indicating that this new approach differentiates vaccinated from infected animals. Lastly, after priming animals with EV-enriched fractions from sera of convalescence animals and boosting them with synthetic viral peptides identified by mass spectrometry, a distinctive high and specific IFN-\xCE\xB3 response was elicited. Altogether, our data strongly suggest the use of serum EV-enriched fractions as a novel vaccine strategy against PRRSV.

Subject

Porc, Malalties infeccioses

Subject (English)

Swine, Communicable diseases

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

MONTANER TARBES, Sergio, et al. Targeted-pig trial on safety and immunogenicity of
                serum-derived extracellular vesicles enriched fractions obtained
                from Porcine Respiratory and Reproductive virus infections. Scientific Reports. 2018. Vol. 8. ISSN 2045-2322. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/134880

Export metadata

JSON - METS

Share record